Search company, investor...

Founded Year

2012

Stage

Unattributed | Alive

Total Raised

$1.05M

About Oncgnostics

Oncgnostics operates as a molecular diagnostics company specializing in the development of in-vitro diagnostic tests for cancer. It aims at the identification and utilization of molecular markers for the early diagnosis of cervical cancer. The company was founded in 2012 and is based in Jena, Germany.

Headquarters Location

Lobstedter Str. 41

Jena, 07749,

Germany

+49 (0)3641 5548500

Loading...

Loading...

Oncgnostics Patents

Oncgnostics has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/29/2013

1/5/2016

Transcription factors, Human proteins, Molecular biology, Small nuclear RNA, Genetics

Grant

Application Date

8/29/2013

Grant Date

1/5/2016

Title

Related Topics

Transcription factors, Human proteins, Molecular biology, Small nuclear RNA, Genetics

Status

Grant

Latest Oncgnostics News

Financing round-up: Scala Biodesign, Tribun Health, Oncgnostics, inContAlert

Sep 13, 2023

Germany: inContAlert, a Beyreuth headquartered medtech startup, has closed its pre-seed financing round of €1.5m (US$1.6m) led by High-Tech Grunderfonds, Bayern Kapital, and Carma Fund, accompanied by renowned business angels from the medical technology domain, such as Prof Dr Thomas Gottwald, former CEO of Fresenius Biotech and Ovesco, Dr Jorg Stein, former executive at Siemens Healthineers, […]

Oncgnostics Frequently Asked Questions (FAQ)

  • When was Oncgnostics founded?

    Oncgnostics was founded in 2012.

  • Where is Oncgnostics's headquarters?

    Oncgnostics's headquarters is located at Lobstedter Str. 41, Jena.

  • What is Oncgnostics's latest funding round?

    Oncgnostics's latest funding round is Unattributed.

  • How much did Oncgnostics raise?

    Oncgnostics raised a total of $1.05M.

  • Who are the investors of Oncgnostics?

    Investors of Oncgnostics include Grand Pharm, bm-t beteiligungsmanagement thuringen, SEEDMATCH, High-Tech Grunderfonds, STIFT and 5 more.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.